Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas

被引:194
|
作者
Loennerdal, Bo [1 ]
机构
[1] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA
来源
关键词
BOVINE LACTOFERRIN SUPPLEMENTATION; ALPHA-LACTALBUMIN SUPPLEMENTATION; FAT GLOBULE-MEMBRANE; ESCHERICHIA-COLI; PROTEOMIC CHARACTERIZATION; PHYSIOLOGICAL SIGNIFICANCE; PUBLISHED EVIDENCE; RHESUS-MONKEYS; BLOOD-PRESSURE; LATER LIFE;
D O I
10.3945/ajcn.113.071993
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Human milk contains an abundance of biologically active components that are highly likely to contribute to the short- and long-term benefits of breastfeeding. Many of these components are proteins; this article describes some of these proteins, such as a-lactalbumin, lactoferrin, osteopontin, and milk fat globule membrane proteins. The possibility of adding their bovine counterparts to infant formula is discussed as well as the implications for infant health and development. An important consideration when adding bioactive proteins to infant formula is that the total protein content of formula needs to be reduced, because formula-fed infants have significantly higher concentrations of serum amino acids, insulin, and blood urea nitrogen than do breastfed infants. When reducing the protein content of formula, the amino acid composition of the formula protein becomes important because serum concentrations of the essential amino acids should not be lower than those in breastfed infants. Both the supply of essential amino acids and the bioactivities of milk proteins are dependent on their digestibility: some proteins act only in intact form, others act in the form of larger or small peptides formed during digestion, and some are completely digested and serve as a source of amino acids. The purity of the proteins or protein fractions, potential contaminants of the proteins (such as lipopolysaccharide), as well as the degree of heat processing used during their isolation also need to be considered. It is likely that there will be more bioactive components added to infant formulas in the near future, but guidelines on how to assess their bioactivities in vitro, in animal models, and in clinical studies need to be established. The extent of testing needed is likely going to depend on the degree of complexity of the components and their bioequivalence with the human compounds whose effects they are intended to mimic.
引用
收藏
页码:712S / 717S
页数:6
相关论文
共 50 条
  • [31] Effects of Chemical Composition and Microstructure in Human Milk and Infant Formulas on Lipid Digestion
    Yuan, Tinglan
    Zhu, Xuemei
    Mu, Guangqing
    Qlan, Fang
    Xiong, Hua
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2020, 68 (19) : 5462 - 5470
  • [32] Standards for infant formula milk
    Koletzko, B
    Shamir, R
    BRITISH MEDICAL JOURNAL, 2006, 332 (7542): : 621 - 622
  • [33] HUMAN-MILK AND MILK FORMULAS FOR INFANT-FEEDING
    LAKHANI, SA
    CHAUDHRI, T
    JANSEN, AAJ
    EAST AFRICAN MEDICAL JOURNAL, 1983, 60 (03) : 181 - 185
  • [34] FAT COMPOSITION OF INFANT FORMULAS
    DEFERRER, PAR
    FASEB JOURNAL, 1995, 9 (04): : A754 - A754
  • [35] TABLES OF COMPOSITION OF INFANT FORMULAS
    不详
    ARCHIVES FRANCAISES DE PEDIATRIE, 1980, 37 (04): : 275 - 277
  • [36] NUTRIENT COMPOSITION OF INFANT FORMULAS
    FLORENCE, E
    KNIGHT, DJ
    HARRIS, WM
    JOURNAL OF THE SOCIETY OF DAIRY TECHNOLOGY, 1987, 40 (02): : 37 - 42
  • [37] CONTROVERSIES IN THE COMPOSITION OF INFANT FORMULAS
    REDEL, CA
    SHULMAN, RJ
    PEDIATRIC CLINICS OF NORTH AMERICA, 1994, 41 (05) : 909 - &
  • [38] Insulin in Human Milk and the Use of Hormones in Infant Formulas
    Shamir, Raanan
    Shehadeh, Naim
    IMPORTANCE OF IMMUNONUTRITION, 2013, 77 : 57 - 64
  • [39] ANTIVIRAL ACTIVITY OF HUMAN-MILK AND INFANT FORMULAS
    ISAACS, CE
    THORMAR, H
    KASHYAP, S
    HEIRD, WC
    PEDIATRIC RESEARCH, 1986, 20 (04) : A390 - A390
  • [40] FATTY-ACIDS OF HUMAN MILK AND OF INFANT FORMULAS
    BEAREROGERS, JL
    GRAY, LM
    HOLLYWOOD, R
    JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1979, 56 (02) : A177 - A177